Saba Malik

AMPAC Fine Chemicals, an SK Pharmteco company, adds additional pharmaceutical development and engineering capabilities with the opening of a new Complex Molecule Chemistry & Engineering Center Rancho Cordova, California, August 24, 2022 AMPAC Fine Chemicals (AFC), an SK pharmteco Company, a leading manufacturer of Active Pharmaceutical Ingredients in the United States, expanded its pharmaceutical manufacturing capabilities …

AMPAC Fine Chemicals Announces Expansion of Capabilities in California Read More »

In a recent interview with Japan Chemical Daily, Aslam Malik, CEO of SK pharmteco, shares the company’s growth in Cell & Gene Therapy and plans to strengthen business in the Japanese market. Read the full article below: SK pharmteco, an US company engaged in CDMO business arm of the South Korean conglomerate SK Group, is making …

Japan Chemical Daily Interview with Aslam Malik Read More »

Click here to see the full agenda and register.

Press Release | For Immediate Release  SK pharmteco Inc (SKPT) is pleased to announce that Joyce Fitzharris, currently serving as General Manager, SK biotek Ireland has been promoted to the office of President, SK biotek Ireland. Growth in our business base and projected expansions continue to support SK biotek Ireland’s position as a key contributor …

SK pharmteco Announces Appointment of a New President for SK biotek Ireland Read More »

PETERSBURG, Va., June 17, 2021  The City of Petersburg, home to AMPAC Fine Chemicals Virginia, declared June 17, 2021 as “AMPAC Day”. An event was held in appreciation of AFC’s employees and to further cultivate a positive relationship with the local community.

Yposkesi Breaks Ground for Second Plant  Seoul, June 14, 2021 (Yonhap) Yposkesi has begun the construction of its second drugmaking plant in France to ramp up its manufacturing capacity.  In March, SK Inc. acquired a 70 percent stake in Yposkesi, a France-based Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapies, to …

Yposkesi Breaks Ground for Second Plant  Read More »

AMPAC Fine Chemicals Creating Jobs with Expansion in Virginia Investment will triple local employment and strengthen regional pharma industry Furthers SK Group’s plans to invest in and grow U.S. businesses PETERSBURG, Va., May 4, 2021 AMPAC Fine Chemicals (AFC), an SK pharmteco company, is creating more than 150 new jobs and investing more than $25 …

AMPAC Fine Chemicals Creating Jobs with Expansion in Virginia Read More »

SK pharmteco Expands into Cell and Gene Therapy With the Acquisition of French CDMO Yposkesi Rancho Cordova, California, April 28, 2021 SK pharmteco, a global contract development and manufacturing organization (CDMO) specializing in the manufacture of active pharmaceutical ingredients (APIs) and advanced intermediates, recently announced the acquisition of the major interest in Yposkesi. Yposkesi is …

SK pharmteco Expands into Cell and Gene Therapy With the Acquisition of French CDMO Yposkesi Read More »

We are delighted to be featured in tks with a company profile by our Global Head of R&D, William DuBay. Click here to view the article.

We are pleased to announce the appointment of Joyce Fitzharris, General Manager, SK biotek Ireland. Joyce has been leading Operations in Swords, Dublin, on an interim basis since Dec 2019. “Joyce has led our Swords Campus through transition & integration into the successful business entity it is today. She is highly respected by all who …

Appointment of Joyce Fitzharris, General Manager, SK biotek Ireland Read More »